If you have spent any time researching weight loss medications or metabolic health, you have heard of Ozempic. It has become a cultural shorthand for an entire class of drugs — GLP-1 receptor agonists — that work by mimicking a hormone your body naturally produces to regulate appetite, blood sugar, and digestion.
What most people do not know is that the active ingredient in Ozempic — semaglutide — can be legally prescribed and compounded by physician-supervised pharmacies, often at 80 to 90 percent less than the brand-name price. This is not a grey market workaround. It is a well-established pathway in American pharmaceutical law, and understanding it could change how you approach your protocol.
What Is Semaglutide?
Semaglutide is a GLP-1 receptor agonist — a molecule that binds to the same receptors as glucagon-like peptide-1, a hormone released in your gut after eating. When those receptors are activated, several things happen: your pancreas releases more insulin in response to glucose, your liver releases less glucose into the bloodstream, and — critically — signals reach your brain that reduce appetite and slow gastric emptying.
The result is that you feel full faster, stay full longer, and experience fewer cravings. Clinical trials have consistently shown 10 to 15 percent body weight reduction over 68 weeks for patients on therapeutic doses of semaglutide, with some patients losing significantly more.
Ozempic is Novo Nordisk's brand-name version of semaglutide, originally approved by the FDA for type 2 diabetes management. Wegovy is the same molecule at a higher dose, approved specifically for weight loss. Both are effective. Both are expensive.
"The active molecule is identical. What you are paying for with Ozempic is the brand name, the pen device, and the manufacturer's pricing strategy."
What Is Compounded Semaglutide?
Compounded semaglutide is semaglutide produced by a licensed compounding pharmacy — a facility that mixes, combines, or alters pharmaceutical ingredients to create customized medications under physician oversight. Compounding has a long history in American medicine and is governed by the FDA and state pharmacy boards.
The key distinction that makes compounded semaglutide both legal and meaningful is the source of the base compound. Not all compounding pharmacies are equal. The highest standard — and the one Foundry RX requires — is a 503B outsourcing facility operating under current Good Manufacturing Practice (cGMP) standards. These facilities are FDA-registered, subject to regular inspections, and held to pharmaceutical-grade quality controls that most compounding pharmacies are not.
What this means in practice: the semaglutide you receive through a compliant telehealth provider like Foundry RX starts from the same pharmaceutical-grade base compounds used in clinical settings, produced under rigorous quality standards, tested for potency and purity, and prescribed by a licensed physician who has reviewed your health history.
Ozempic vs. Compounded Semaglutide:
A Direct Comparison
| Factor | Ozempic (Brand) | Compounded Semaglutide |
|---|---|---|
| Active Ingredient | Semaglutide | Semaglutide |
| Monthly Cost | $900 – $1,300+ | $150 – $350 |
| Insurance Coverage | Sometimes covered for diabetes | Not covered; priced accordingly |
| Prescription Required | Yes | Yes |
| Physician Oversight | Yes | Yes (via telehealth) |
| Sourcing Standard | FDA-approved manufacturer | 503B cGMP facility (at Foundry RX) |
| Dose Customization | Fixed pen doses | Flexible, titrated to patient |
| Availability | Subject to shortage | Consistently available |
Why Has Ozempic Been in Short Supply?
Demand for semaglutide has significantly outpaced Novo Nordisk's manufacturing capacity since 2022. The FDA placed semaglutide on its drug shortage list, which had an important legal consequence: compounding pharmacies were permitted to produce and distribute compounded versions of shortage-listed drugs at scale. This opened a compliant, legal pathway for patients who could not access or afford the brand-name product.
As shortage designations shift, the regulatory landscape continues to evolve. This is one reason why working with a physician-supervised telehealth provider — rather than purchasing from unvetted sources — matters. A legitimate provider monitors regulatory changes and ensures your protocol remains on solid legal and clinical ground.
Is Compounded Semaglutide Safe?
The safety of compounded semaglutide depends almost entirely on where it comes from and how it is prescribed. The FDA has been explicit: compounded semaglutide from facilities that do not meet quality standards poses real risks, including incorrect dosing, contamination, and unknown impurities.
This is not a theoretical concern. Reports of adverse events from unverified online sources have been documented. The difference between a risky compound and a safe one is not the molecule — it is the facility, the testing, the physician oversight, and the supply chain.
At Foundry RX, every compound is sourced from a 503B cGMP-certified outsourcing facility with full lot traceability. This is the same standard applied to hospital-grade pharmaceutical compounding. It is not the floor — it is meaningfully above most of what is available in the compounded peptide market.
Physician-supervised GLP-1 therapy.
503B cGMP sourced. 50-state delivery.
Who Should Consider Compounded Semaglutide?
Compounded semaglutide is worth exploring for patients who have been prescribed GLP-1 therapy but face cost or availability barriers with brand-name products, and who want to work with a physician to establish a properly titrated, medically supervised protocol.
It is not appropriate for everyone. A physician should review your full health history before prescribing — including any history of pancreatitis, thyroid conditions, or contraindicated medications. The Foundry RX intake process includes this review as a standard part of membership.
The Bottom Line
Compounded semaglutide and Ozempic contain the same active molecule. The differences are cost, customization, and sourcing standards. When compounded correctly — from a 503B cGMP facility, under physician supervision, through a compliant telehealth provider — compounded semaglutide offers a clinically sound, significantly more accessible path to GLP-1 therapy.
The question is not whether to choose brand-name or compounded. The question is whether your provider can verify exactly where your compound comes from and what standards it was held to. If they cannot answer that clearly, that is your answer.